WE HAVE THE EXPERIENCE
Our expertise and experience combine to create results and efficiencies. Most CROs do not have the combined years of product approval, patents, and publication experience specifically in IVDs. As an emerging company we are nimble and flexible while augmenting your team's capabilities cost effectively without compromising quality or impact. We are the most knowledgeable and experienced Clinical Research Organization (CRO) for IVD development.
​
Let us show you why!
WHY LAKESIDE?
We have the team, the experience, and the culture.
WE HAVE THE RESULTS
Our results and reviews speak for themselves. With over 100 analytical studies successfully designed and implemented, our team will deliver the results you need to innovate, release new technologies, and improve patient lives.
100
Analytical Studies designed & implemented
34
Clinical Studies designed & implemented
54
FDA submissions with none denied or withdrawn
195
IVD related
Publications
20
IVD Related Patents
WE HAVE THE CULTURE
Here at Lakeside, we maintain a relaxed atmosphere and highly technical skillsets. We prioritize our customers through customer-centric services, making the experience of working with us enjoyable and productive. We ensure that our clients feel well taken care of. Our team is focused on integrity, putting people first, advancing IVD science, always moving forward, and enjoying the journey.
WE HAVE THE TEAM
We are committed to advancing IVD science alongside our clients. Our team of professionals has been carefully selected for their highly specialized skillsets in order to provide the best possible services for our clients. The Lakeside team is knowledgeable, reliable, friendly, and flexible.
CLIENT TESTIMONIALS
Lakeside puts people first. Our team works seamlessly with others to consistently deliver great results, and our client feedback reflects that.
CHIEF EXECUTIVE OFFICER
“ANGLE engaged Lakeside Life Sciences to identify, initiate and manage several clinical oncology sites for one of our clinical studies. They identified and initiated five separate sites (both community and academic oncology practices) located throughout the US and got patient enrollment underway in less than four months. Their staff is extremely knowledgeable, professional and personable, and we are grateful for their responsive approach.”